Date post: | 22-Feb-2018 |
Category: |
Documents |
Upload: | indah-maulana-sari |
View: | 218 times |
Download: | 0 times |
of 17
7/24/2019 Pi is 0002937813006261
1/17490.e1 American Journal of Obstetrics & Gynecology NOVEME! "01#
!
$G$ %a&ers '''.AJOG.org
$urgical site infection after (ysterectomyAeuMuro Gas(a' )a*e+ M,- Alean/ra M. Mc%enco'+ M,- Ma/eline A. ,ic*iascoec(ea+ M,-
,eanna . Martin+ M%2- Elisabet( A. Ere*son+ M,+ M%2
OJE35VE6 Our ob7ecti8e 'as to estimate t(e occurrence of surgical site infections $$5: after (ysterectomy an/ t(e associate/ ris*
factors.
$;,< ,E$5GN6 =e con/ucte/ a crosssectional analysis of t(e"00>
"009 American 3ollege of $urgeons National $urgical ?uality
n @ ""1 'omen:. !is* factors t(at 'ere associate/ 'it( cellulitis'ere route of (ysterectomy 'it( an a/7uste/ o//s ratio 9AO!: of #.4
9>B confi/ence inter8al C35D+ "."e."":for la&arotomy com&are/
'it( t(e 8aginal a&&roac(+ o&erati8e time F>t( &ercentileAO!+
1.4- 9>B 35+ 1.40e".44:+American $ociety of Anest(esia class #"
5m&ro8ement %rogram &artici&ant use /ata files to analyHe (ysterec 9AO!+ 1.9- 9>B 35+ 1.#1e".4#:+bo/y mass in/e 40*gIm
9AO!+
tomies. ,ifferent routes of (ysterectomy 'ere com&are/. (e&rimaryoutcome 'as to i/entify t(e occurrence of #0/ay su&erficial $$5cellulitis: after (ysterectomy. $econ/ary outcomes 'ere t(e occur
rence of /ee an/ organs&ace $$5 after (ysterectomy. )ogisticregression mo/els 'ere con/ucte/ to furt(er e&lore t(e associationsof ris*s factors 'it( $$5 after (ysterectomy.
!E$;)$6 A total of 1#+"" 'omen 'ere inclu/e/ in our final analysis.
(e occurrence of &osto&erati8e cellulitis after (ysterectomy 'as
1.B
".>- 9>B 35+ 1.>e#.0:+ an/ /iabetes mellitus 9AO!+ 1.>4- 9>B35+
1.0e"."4: (e occurrence of /ee& an/ organs&ace $$5 'as
1.1B n @ 1>4 'omen: after (ysterectomy.
3ON3);$5ON6 Our fin/ing of t(e /ecrease/ occurrence of su&erficial
$$5 after t(e 8aginal a&&roac( for (ysterectomy reaffirms t(e role for
8aginal (ysterectomy as t(e route of c(oice for (ysterectomy.
ey 'or/s6 (ysterectomy+ outcome+ &osto&erati8e com&lication+surgical site infection
3ite t(is article as6 )a*e AG+ Mc%enco' AM+ ,ic*iascoec(ea MA+ et al. $urgical site infection after (ysterectomy. Am J Obstet Gynecol "01#-"096490.e19.
ecently+ ;nite/ $tates (ealt(care
initiati8es sonsore/ by t(e 3en
ters for Me/icare an/ Me/icai/ $er8ices3M$: an/ t(e Joint 3ommission on
t(e Accre/itation of 2ealt(care Organi
Hations (a8e targete/ &re8entable
(os&ital acuire/ infections+ suc( as
ostoerati8e surgical site infections
$$5:+ as a riority in imro8ing atient
safety. Effecti8e January "01"+ 3M$
reuire/ all Me/icare certiKe/
(ositals to ublically re&ort clinical
/ata an/ outcome measures in a
L$ystematic 3linical ,atabase !egistry for
General $urgery in t(e 2os&ital5n&atient
?uality !eorting %rogram.1
(e
conse uence for an institution or
(osital not reorting 'ill be aayment enalty as of October "01#.
(e " surgical roce/ures t(at 'ere
i/entiKe/ by 3M$ in t(is recent
man/ate for &ublic re&orting of
ostoerati8e $$5 are colon surgeryan/ (ysterectomy.
O8er t(e last " /eca/es+ remar*able
a/8ancements (a8e been ma/e in t(e
c(oice of (ysterectomy routes. Alt(oug(t(e occurrence an/ ris* factors of
$$5 after total ab/ominal (ysterectomy
A2: (as been reorte/+" neit(er t(e
occurrence nor t(e ris* factors of&ost
(ysterectomy $$5 (a8e been reorte/
by (ysterectomy route."4 etter un/erstan/ing of ris* factors for $$5 after
(ysterectomy can (el target efforts at
t(e re/uction of mo/iKable ris*s to
re8ent infections. A//itionally+ un/er
stan/ing ris* factors for $$5 after
(ysterectomy can lea/ to better ris*
stratiKcation in t(e reorting of uality
outcomes. Our ob7ecti8e 'as to estimate
t(e occurrence of #0/ay ostoerati8e
$$5 after all routes of (ysterectomy an/to i/entify associate/ ris* factors.
rom t(e ,eartment of Obstetrics+ Gynecology+ an/ !ero/ucti8e $ciences+
7/24/2019 Pi is 0002937813006261
2/17NOVEME! "01# American Journal of Obstetrics & Gynecology 490.e"
MAE!5A)$ AN, ME2O,$=e con/ucte/ a secon/ary /atabase analysis of t(e "00>"009 American 3ollege
of $urgeons National $urgical ?uality 5mro8ement %rogram A3$ N$?5%:
articiantuse /ata Kles to analyHe t(e /ata of 'omen '(o un/er 'ent
(ysterectomies erforme/ by gy necologic ser8ices. (e A3$ N$?5% is a
national rogram for surgical uality
imro8ement t(at collects uniform /ata
on atients '(o un/ergo surgical&ro
ce/ures. 2osital articiation in t(e
A3$ N$?5% rogram is 8oluntary an/
000"9#IP#.00 Q "01# Mosby+ 5nc. All rig(ts reser8e/. (tt& 6 II/./oi.or g I10.101I7.a7og."01#.0.01 conK/ential. (is information is col
lecte/ by a formal c(art re8ie' rocess
http://dx.doi.org/10.1016/j.ajog.2013.06.018http://dx.doi.org/10.1016/j.ajog.2013.06.018http://dx.doi.org/10.1016/j.ajog.2013.06.018http://dx.doi.org/10.1016/j.ajog.2013.06.0187/24/2019 Pi is 0002937813006261
3/17
$G$ %a&ers '''.AJO G .org
A)E 1
,emogra&(ic an/ clinical c(aracteristics of #0/ay ostoerati8esuerficial surgical site infection after (ysterectomy n C1#+"" 'omen:
an/ its uality control measures are
furt(er /escribe/ on t(eir 'ebsite
(t t6 II'' ' .a c sns i .o r g:. Eemtion
status for t(is stu/y 'as obtaine/ in
'riting from t(e .4: "> 0.: .49
Et(nicity6 2is&anic+ n B: " 1".": "10 1.0: .14
,iabetes mellitus+ n B: 41 1.: 9" ."B: R .001
Eclusion criteria inclu/e/ 1:
male se+ ": 'omen 'it( t(e
/iagnosis of current ®nancy+ #:
surgical &roce/ure 'it(in #0 /ays
before (ysterectomy+ 4: 3urrent
%roce/ural erminology 3o/ing $ystem+
4t( e/ition 3%4:+ co/e incon sistent
'it( (ysterectomy+ >: 3%4 co/e t(at
in/icates el8ic eenteration &roce
2istory of cerebro8ascular acci/ent'it( neurologic /eficit+ n B:
1 0.>: > 0.>B: 1.0 /ure at t(e time of (ysterectomy+ an/ :
'omen 'it( a /iagnosis of reoerati8e3urrent smo*er+ n B: >1 "#.1: "1 19.B: ."0
o/y mass in/e+ n B: R .001
R#0 *gIm"
#>.#: >9 >>.9:
#0 an/ R40 *gIm"
4 ##.>: 4>4 ##.:
40 *gIm"
9 #1.": 14#9 10.:
Ascites+ n B: ".: 104 0.: R .01
a
infection t(at inclu/es sesis+ systemic
inammatory resonse syn/rome+ an/
setic s(oc* imme/iately before (yster
ectomy. After eclusion for t(ese
criteria+ t(e remaining articiants
'ere 'omen '(o un/er'ent
(ysterectomy.
2ysterectomy route 'as assigne/
base/on 3%4 co/ing of t(e rimary&ro
;nintentional 'eig(t loss+ n B:
unctional status6 /e&en/ent for acti8itiesof /aily li8ing+ n B:
2ysterectomy for gynecologiccancer+ n B:
%reo&erati8e anemia6 (ematocrit9R#B:+n B:
%reo&erati8e creatinine le8elF1.>mgI/)+ n B:
American $ociety of Anest(esiologists
class #+ n B:
4 1.: " 0.>: .0"
" 0.9: 9 0.: .
#" 14.>: 1 .4: R .001
4 "".#: "9 "".: .94
# 1.: > 0.9: .1
9# 4".1: ">"1 1.>: R .001
ce/ure6 A2+ ab/ominal
suracer8ical (ysterectomy $32:+
total 8aginal (ys terectomy V2:+
laaroscoicassiste/ 8aginal
(ysterectomy )AV2:+ total laa
roscoic (ysterectomy )2:+ an/
laa roscoic $32 )A$32:. =e
furt(er eamine/ $$5 base/ onab/ominal in cisions6 1: laarotomy
A2 or $32:+ ": laaroscoic
incisions )AV2+ )2+ or )A$32:+ or
#: V2. inally+ 'e eamine/ $$5
base/ on 8aginal cuff in
5ntrao&erati8e bloo/ transfusion+ n B: 1> .: #"9 ".4: R .001
b
cisions6 1: no 8aginal cuff incisions $32
or )A$32: 8s ": 8aginal cuff incisions
=or* relati8e 8alue unit
O&erati8e time F>t(&ercentile/uration+ n B:
1. >.1 1.# #. R .001
9# 4".1: ## "4.: R .001
A2+ V2+ )AV2+ an/ )2:.
!is* factors for $$5 'ere elore/
an/ groue/ into t(e follo'ingcategories6
y&e of anest(esia6 general+ n B: ""1 100.0: 1#+111 9.4: .001
http://www.ajog.org/http://www.ajog.org/http://www.acsnsqip.org/http://www.acsnsqip.org/http://www.acsnsqip.org/http://www.acsnsqip.org/http://www.ajog.org/7/24/2019 Pi is 0002937813006261
4/17
$G$ %a&ers'''.AJOG.org=oun/ class+ n B: .0
13lean 0 ## 0.":
"3leanIcontaminate/ "1> 9.#: 1#+44# 9.:
#3ontaminate/ > ".#: 9" 0.:
4,irty 1 0.>: ## 0.":
a)oss of 10B of bo/y 'eig(t in t(e &re8ious mont(s not because of eercise or /ieting-
b,ata are gi8en as mean $,.
)a*e. $urgical site infections after (ysterectomy. Am J Obstet Gynecol "01#.
/emogra(ic features+ reoerati8e
me/ ical comorbi/ities+ an/
intraoerati8e factors. ,emogra(ic
features inclu/e/ age+ race+ an/
et(nicity. =omen 'ere /ic(otomiHe/
into t(e " age categories R0 yearsol/ an/ 0 years ol/: because of a
re8iously /emonstrate/ nonlinear
association bet'een age an/ t(e log
o//s of ostoerati8e infection.
%reoerati8e comorbi/ities inclu/e/
me/ical /iag noses+ obesity+
(ysterectomy for gyneco logic
cancer+ reoerati8e functionalin a//ition to a #0/ay &osto&era
ti8e follo'u e8aluation of atients.>
Variables t(at are collecte/ inclu/e
reoerati8e c(aracteristics+ surgical in
formation+ an/ #0/ay ostoerati8e
com&lications. (e A3$ N$?5%
/atabase
status+ unintentional 'eig(t loss+
&reo& erati8e laboratory /ata+ an/
American $ociety of Anest(esia A$A:
classiKcation.
http://www.ajog.org/http://www.ajog.org/7/24/2019 Pi is 0002937813006261
5/17
Me/ical /iagnoses t(at 'ere
consi/ere/ inclu/e/ /iabetes mellitus+ a
(istory of cerebro8ascular acci/ents
3VA: 'it( neurologic /eKcit+ ascites+
reoerati8e corticosteroi/ use+ an/
obesity. Obesity 'as classiKe/ base/ on
bo/y mass in/e M5:. =omen 'erecategoriHe/ as (a8 ing normal 'eig(t
M5+ R#0 *gIm":+ obesity M5+ #0
an/ R40 *gIm":+ an/ morbi/ obesity
M5+ 40 *gIm":.
=omen '(o (a/ un/ergone (ysterec
tomies for gynecologic cancer 'ere
i/en tiKe/ by 3%4 co/es t(at 'ere
consistent 'it( lym( no/e /issection
or ra/ical /ebul*ing+ t(e /iagnoses of
reoerati8e ascites+ reoerati8e
/isseminate/ cancer+ reoerati8e
c(emot(eray+ an/ &reo& erati8era/iation t(era&y. unctionalstatus 'as
/eKne/ as a 'omanSs ability to
erform acti8ities of /aily li8ing+
'(ic( inclu/e/ bat(ing+ fee/ing+
/ressing+ toi leting+ an/ mobility an/
'as categoriHe/ as eit(er in/een/ent
or /een/ent. ;n intentional 'eig(t
loss 'as use/ as a mar*er of frailty
an/ 'as /eKne/ as loss of F10B of
bo/y'eig(t o8er t(e re8ious
mont(s. %reoerati8e laboratory /ata
'ere use/ to i/entify anemia an/ renalcomromise. Anemia 'as /eKne/ as
(e matocrit of R#B base/ on t(e
Kn/ings of =u et al
an/ 2eisler et
al.9
!enal com&romise 'as /eKne/ as a
creatinine le8el of F1.>mgI/) base/ on
t(e Kn/ings of ,o'/y et al.10
5ntraoerati8e factors t(at 'ere
elore/ inclu/e/ t(e tye of
/ata Kle of t(e A3$ N$?5%.1"
(ese
/eKnitions 'ere also base/ on criteria
set by t(e 3enters for ,isease 3ontrol
an/ %re8ention 3,3:.1#
(e rimary
outcome 'as t(e occurrence of #0/ay
suerKcial $$5 cellulitis: after (ys
terectomy. 3ellulitis 'as /eKne/ as an
infection t(at in8ol8e/ only s*in or
subcutaneous tissue of t(e surgical inci
sion. $econ/ary outcomes 'ere t(e
occurrence of /ee an/ organsace
$$5 an/ urinary tract infection ;5:
after (ysterectomy. ,ee an/ organ
sace $$5 inclu/e/ infections t(at
in8ol8e/ /ee soft tissues fascia an/
muscle: at an/ aroun/ t(e surgical
incision an/ in fections in any art
of t(e bo/y t(at 'as oene/ or
maniulate/ /uringt(e oerati8e roce/ure. (is inclu/es
8aginal cuff cellulitis an/ 8aginal cuff
abscess+ eritonitis+ an/ el8ic abscess.
,ee an/ organsace $$5 'ere consi/ere/ as 1 category+because t(ese " cate
gories 'ere /ifKcult to /istinguis( '(en
(ysterectomy is consi/ere/ to be t(e
rimary roce/ure. inally+ 'e eam
ine/ ostoerati8e ;5+ '(ic( 'as
/eKne/ by 3,3 criteria for
symtomatic ;5 an/ asymtomatic
bacteriuria+ '(ic( ta*e into accountt(e recent use of in/'elling cat(eters
an/ t(e age of t(e&atient.1#
A)E "
,escriti8e statistics+ $tu/ent t test+
%earson c"+ an/ is(er eact test"si/e/: 'ere erforme/ for bi8ariate
analysis. (ree logistic regression mo/els
'ere con/ucte/ to furt(er elore t(e
associations of ris*s factors for
cellulitis+ /ee an/ organsace $$5+an/ &ost oerati8e ;5 after
(ysterectomy.+9
Variables t(at 'ere associate/ 'it(
$$5 'ere i/entiKe/ for otential
inclusion in t(e Knal mo/el base/ on
bi8ariate analysis % R .1:. Variables
'ere a//e/ to t(e mo/el in a
ste'ise fas(ion 'it( t(e use of
for'ar/ selection %.0>:. A/7uste/ o//s ratios AO!s:
an/
9>B conK/ence inter8als 35s: 'erecalculate/. $tatistical analysis 'as &er
forme/ 'it( $AA statistical
soft'are 8ersion 11.0- $tata
3ororation+ 3ollege $tation+ T: an/
$A$ statistical soft'are 8ersion 9."-
$A$ 5nstitute 5nc+ 3ary+ N3:.
!E$;)$A total of "#+>9 articiants 'ere
classiKe/ as (a8ing un/ergone a gyne
cologic roce/ure in t(e "00>
"009A3$ N$?5% articiant use /ataset.
(e follo'ing eclusions 'ere ma/e
from t(e Knal analysis6 1: male se
n @ >1:+ ": 'omen 'it( t(e /iagnosis
of current regnancy n @ 41:+ #:
surgical roce/ure 'it(in #0 /ays
anest(esia+ 'oun/ classiKcation+ intra
oerati8e bloo/ transfusion+ an/ &roce
/ural /ifKculty. 3oncomitant roce/ures
an/ roce/ural /ifKculty 'ereaccounte/ for by an eamination of t(e
total 'or* relati8e 8alue units an/
total oerati8e time. %roce/ures (a/
bet'een 1 an/
3% co/es. o consi/er t(e com&leity
of all t(e /ifferent &ossible
combinations of
)ogistic regression mo/el for association of cellulitis after (ysterectomy
Variable A/7uste/ o//s ratio 9>B 35 % 8alue
!oute of (ysterectomy
otal 8aginal (ysterectomy referent: 1 U U
)aarotomya
#.4 "."e."" R .001
)a&arosco&ic incisionsb
1.4> 0.#e".> ."0
O&erati8e time F>t(&ercentile /uration 1.4 1.40e".44 R .001
roce/ures+ 'or* relati8e 8alue units
for all concomitant roce/ures 'ere
totale/. Oerati8e time 'as
categoriHe/ as a
American $ociety of Anest(esiologists
class #
o/y mass in/e+ *gIm"
1.9 1.#1e".4# R .001
/ic(otomous 8ariable abo8e an/ belo'
t(e >t( ercentile+ base/ on
&re8ious 'or*by 3ul8er et al+11
'(o
/emonstrate/ t(at o&erati8e time ofF
>t(&ercentileisa ris* factor for $$5. or(ysterectomies in t(e A3$ N$?5% /ataset+ t(e o&erati8e time ofF>t(&ercentile 'as 149 minutes. $$5 categories 'ere /eKne/ by t(e criteria foun/
7/24/2019 Pi is 0002937813006261
6/17
in t(e articiant use
R#0 referent: 1 U U
#0 an/ R40 1.#1 0.94e1.1 .11
40 ".> 1.>e#.0 R .001
,iabetes mellitus 1.>4 1.0e"."4 .0"
a)a&arotomy inclu/e/ total ab/ominal (ysterectomy an/ su&racer8ical (ysterectomy-
b)a&arosco&ic incisions inclu/e/
la&arosco&icassiste/ 8aginal (ysterectomy+ total la&arosco&ic (ysterectomy+ an/ la&arosco&ic su&racer8ical (ysterectomy.
)a*e. $urgical site infections after (ysterectomy. Am J Obstet Gynecol "01#.
7/24/2019 Pi is 0002937813006261
7/17
A)E #
,emogra&(ic an/ clinical c(aracteristics of #0/ay ostoerati8e /ee or organsace surgical siteinfection after (ysterectomy nC 1#+"":
Variable
$urgical site infection
,ee&Iorgans&ace
nC 1>4:
No /ee&Iorgans&ace
nC 1#+: % 8alue
Age+ n B: 1.0
R0 y 1>" 9.: 1#+444 9.4:
0 y " 1.#: ""4 1.:
!ace6 '(ite+ n B: # 4.4: #"1 0.9: .001
Et(nicity6 2is&anic+ n B: #" "0.: "1> 1>.9: .1"
,iabetes mellitus+ n B: "# 14.9: 1000 .#: R .01
2istory of cerebro8ascular acci/ent 'it( neurologic /eficit+ n B: 4 ".: " 0.>: R .01
3urrent smo*er+ n B: 4 #0.>: "> 19.: .001
o/y mass in/e+ n B: R .001
R#0 *gIm"
44.": 0 >>.:
#0 an/ R40 *gIm"
>0 #".>: 4> ##.:
40 *gIm"
# "#.4: 14" 10.:
Ascites+ n B: 4 ".: 10 0.: .04
;nintentional 'eig(t loss+ n B:a
" 1.#: 4 0.>: .1
unctional status6 /e&en/ent for acti8ities of /aily li8ing+ n B: " 1.#: 9 0.: .#0
2ysterectomy for gynecologic cancer+ n B: 1# .4: 90 .>: .#"
%reo&erati8e anemia6 (ematocrit 9R#B:+n B: >0 ##.: "94 "".: R .01
%reo&erati8e creatinine F1.>mgI/)+ n B: # ".: > 0.9: .0
American $ociety of Anest(esiologists class #+ n B: >4 #>.1: ">0 1.: R .001
5ntrao&erati8e bloo/ transfusion+ n B: >.": ## ".>: .0
=or* relati8e 8alue unitb
1. 4. 1.# #. .1#
O&erati8e time6 F>t(&ercentile /uration+ n B: >1 ##.1: #4"0 ">.0: .0#
y&e of anest(esia6 general+ n B: 14 9.1: 1#+14 9.>: ."
=oun/ class+ n B: .1
13lean 0 ## 0.":
"3leanIcontaminate/ 1>0 9.4: 1#+>0 9.:
#3ontaminate/ # ".0: 94 0.:
4,irty 1 0.: ## 0.":
a)oss of 10B of bo/y 'eig(t in t(e &re8ious mont(s not because of eercise or /ieting-
b,ata are gi8en as mean $,.
)a*e. $urgical site infections after (ysterectomy. Am J Obstet Gynecol "01#.
before (ysterectomy n @ 1>:+ 4:3%
4 co/e inconsistent 'it( (ysterectomy
n @ 94#:+ >: 3%4 co/e t(at in/i
cate/ el8ic eenteration roce/ure att(e time of (ysterectomy n @ 10:+ an/
: 'omen 'it( /iagnosis of &reo&
erati8e infection t(at inclu/e/
sesis+ systemic inammatory
resonse syn /rome+ an/ setic
s(oc* imme/iately
before (ysterectomy n @ 14":. A total of
1#+"" 'omen un/er'ent (ysterectomy
an/ 'ere inclu/e/ in our Knal analysis.
3ellulitis(e o8erall occurrence of cellulitis
suerKcial $$5: after (ysterectomy 'as
7/24/2019 Pi is 0002937813006261
8/17
1.B nIN @ ""1I1#+"":. our 'omen
0.0#B: recei8e/ a /iagnosis of bot(ostoerati8e cellulitis an/ /ee or
organs&ace $$5. 'el8e 'omen
0.0B: recei8e/ a /iagnosis of bot(
&ost oerati8e cellulitis an/ ;5.
Variables t(at 'ere associate/ 'it(
cellulitis on bi8ariate analysis
inclu/e/ /iabetes mellitus % R .
001:+ M5 category % R
.001:+ reoerati8e ascites % R .
01:+ unintentional 'eig(t loss % @.0":+
7/24/2019 Pi is 0002937813006261
9/17
(ysterectomy for cancer % R .001:+
A$A class # % R .001:+ 'or* relati8e
8alue unit % R .001:+ use of general
anest(esia % @.001:+ an/ an o&erati8e
time F>t( ercentile % R .001- able
1:.
A)E 4
)ogistic regression mo/el for association of /ee or organ s&acesurgical site infection after (ysterectomy
A/7uste/ o//s
Variables t(at 'ere associate/ 'it(#0/ay ostoerati8e cellulitis on mul
ti8ariate logistic regression 'ere t(e route
VariableAmerican $ociety of Anest(esiologists
class #
ratio 9>B 35 % 8alue1.1 1.">e"." R .01
of (ysterectomy 'it( an AO! of #.4
3urrent smo*er 1.99 1.40e".# R .0019>B 35+ "."e."": for laarotomy in
cisions comare/ 'it( 8aginal a&&roac(+
oerati8e time F>t( ercentile
AO!+
2istory of cerebro8ascular acci/ent'it( neurologic /eficit
4.41 1.>4e1".> R .01
1.4- 9>B 35+ 1.40e".44:+A$A class #
AO!+ 1.9- 9>B 35+ 1.#1e".4#:+
morbi/ obesity M5+ 40 *gIm"-
AO!+ ".>-9>B 35+ 1.>e#.0:+ an/ /iabetes mel
litus AO!+ 1.>4- 9>B 35+ 1.0e"."4-
able ":.
,ee& an/ organsace $$5
(e occurrence of /ee an/ organ
sace
$$5 'as 1.1B nIN @ 1>4I1#+"": after
%reo&erati8e anemia (ematocrit+ R#B: 1." 1."1e".4# R .01
o/y mass in/e+ *gIm"
R#0 referent: 1 U U
#0 an/ R40 1.19 0."e1.4 .#
40 "."# 1.4#e#.49 R .001
35+confi/ence inter8al.
)a*e. $urgical site infections after (ysterectomy. Am J Obstet Gynecol "01#.
(ysterectomy. No 'omen 'ere catego
riHe/ as (a8ing bot( a /ee s&ace $$5
an/ an organsace $$5. 'entyone
'omen 0.1B: 'ere /iagnose/ 'it(bot( &ost o&erati8e /ee&Iorgans&ace$$5 an/ ;5. Variables t(at 'ereassociate/ 'it( /ee an/ organs&ace$$5 on bi8ariate analysis inclu/e/ race% @ .001:+ /iabetes mel litus % R .
01:+ (istory of 3VA 'it( neurologic
/eKcit % R .01:+ current smo*ing %
@ .001:+ obesity category % @ .11:+
reoerati8e ascites % @ .04:+
reoerati8e anemia % R .01:+ A$A
class # % R .001:+ an/ an oerati8e
time F>t( ercentile % @ .0#- able
#:.
Variables t(at 'ere associate/ 'it(
/ee& an/ organs&ace $$5 on
multi8ariate logistic regression inclu/e/
A$A class # AO!+ 1.1- 9>B 35+
1.">e".":+current smo*ing AO!+
1.99- 9>B 35+
1.40e".#:+(istory of 3VA 'it( neuro
logic /eKcit AO!+ 4.41- 9>B 35+
1.>4e1".>:+ &reo&erati8e anemiaAO!+
1."- 9>B 35+ 1."1e".4#:+ an/ morbi/
obesity AO!+ "."#- 9>B 35+1.4#e#.49- able 4:. =(en 'e
eamine/ (ysterec tomy route+ bot(
by ab/ominal incisions an/ by
8aginal cuff incisions+ 'it( /ee an/
organs&ace $$5+ 'e /i/ not Kn/ anysigniKcant associations.
;
45
%ostoerati8e ;5 occurre/ in ".B
of 'omen nIN @ #0I1#+"":
after
(ysterectomy. Variables t(at 'ere asso
ciate/ 'it( ostoerati8e ;5 on bi8ar
iate analysis inclu/e/ (istory of 3VA
'it( neurologic /eKcit % @ .01:+ A$A
class # % R.01:+ an/ an o&erati8e time
F>t( ercentile % R .001- able >:.
Variables t(at 'ere associate/ 'it( &ost
oerati8e ;5 on multi8ariate logistic
regression 'ere a (istory of 3VA 'it(
neurologic /eKcit AO!+ #."9- 9>B 35+
1.41e.0:+ current corticosteroi/ use
AO!+ ".#- 9>B 35+ 1.14e4.90:+ an/
oerati8e time F>t( ercentile AO!+
1.- 9>B 35+ 1.>"e"."9-able :.
Occurrence of $$5by route of
(ysterectomy
=(en 'e eamine/ /ifferent routes
of (ysterectomy A2+ $32+ )2+
)A$32+ )AV2+ an/ V2:+ 'e notice/
similarities in t(e occurrence of $$5
by ab/ominal incision ty&e able :. =e
eamine/ routes of (ysterectomy solely
base/ on ab/ominal incisions la&arot
omy+ laaroscoic incisions+ an/ no
ab/ominal incisions: an/ note/ t(at t(e
route of (ysterectomy 'as associate/
'it( su&erKcial $$5+ but not /ee&Iorgan
sace $$5 or ostoerati8e ;5. inally+
'e eamine/ t(e association of &ost
7/24/2019 Pi is 0002937813006261
10/17
(ysterectomy $$5 by t(e resence or
absence of 8aginal cuff incisions $32 8s
8aginal colotomy: an/ foun/ no asso
ciation 'it( any ostoerati8e $$5.
3OMMEN
=e foun/ t(e o8erall occurrence of
bot(
#0/ay cellulitis suerKcial $$5:
an/ /ee an/ organsace $$5 after
(yster ectomy to be ".B. (e
occurrence of ;5 after (ysterectomy
'as #.0B.
(e follo'ing ris* factors 'ereassoci ate/ 'it( t(e occurrence of
ostoerati8e cellulitis6 (ysterectomy
route+ oerati8e time F>t(
ercentile 149 minutes:+ A$A class
#+ /iabetes mellitus+ an/ obesity
category M5+ 40 *gIm":. =e /i/
not Kn/ smo*ing status or (ysterec
tomy for gynecologic cancer to be
in/e en/ent ris* factors for
ostoerati8e cellulitis.
Our Kn/ing of t(e /ecrease/
occur rence of suerKcial $$5 aftert(e 8aginal aroac( for (ysterectomy
reafKrms t(e longareciate/ role for
8aginal (yster ectomy as t(e route of
c(oice for (yster ectomy.141
)aarotomy in/een/ently increase/
t(e ris* of suerKcial $$5 after(ysterectomy. A tren/ 'as seen for
increase/ $$5 'it( trocar incisions
minimally in8asi8e (ysterectomies:+
but t(is 'as not statistically signiKcant.
Our Kn/ings a// to re8ious
'or* 'it( National 2ealt(care $afetyNet'or* N2$N: /ata to eamine
$$5."+1
(e N2$N is an internet
base/ sur8eillance systemt(at isuse/by t(e 3,3 to monitor (osital
acuire/ infections t(at inclu/e $$5.1
Originally+ t(e N2$Nbase/ ris*
7/24/2019 Pi is 0002937813006261
11/17
A)E >
,emogra&(ic an/ clinical c(aracteristics of #0/ay ostoerati8e urinary tract infection after (ysterectomynC 1#+"":
Variable;rinary tract infectionnC 40":
No urinary tractinfection nC 1#+4"0: % 8alue
Age+ n B: .1
R0 y #9" 9.>: 1#+"04 9.4B:
0 y 10 ".>: "1 1.B:
!ace6 '(ite+ n B: ">9 4.4: 1#> 0.B: .1#
Et(nicity6 2is&anic+ n B: > 14.": "1>0 1.0B: .#
,iabetes mellitus+ n B: "# >.: 1000 .>: ."1
2istory of cerebro8ascular acci/ent 'it( neurologic/eficit+ n B:
1.>: 0 0.>: .01
3urrent smo*er+ n B: 90 "".4: "#" 19.: .1
o/y mass in/e .4"
R#0 *gIm"
"1> >#.>: 41 >>.:
#0 an/ R40 *gIm"
14 #.: 4491 ##.>:
40 *gIm"
40 10.0: 14 10.9:
Ascites+ n B: " 0.>: 10 0.: .
;nintentional 'eig(t loss+ n B:a
4 1.0: " 0.>: .1#
unctional status6 /e&en/ent for acti8ities of /ailyli8ing+ n B:
1.>: 9# 0.: .0
2ysterectomy for gynecologic cancer+ n B: " .>: .>: 1.00
%reo&erati8e anemia6 (ematocrit 9R#B:+n B: 9 "0.: "94> "".9: .#"
%reo&erati8e creatinine F1.>mgI/)+ n B: # 1.": > 0.9: .>1
American $ociety of Anest(esiologists class #+ n B: 99 "4.: ">1> 1.: R .01
5ntrao&erati8e bloo/ transfusion+ n B: 9 ".": ##> ".>: .
=or* relati8e 8alue unitb
1.1 #. 1.# #. .##
O&erati8e time6 F>t(&ercentile /uration+ n B: 1># #.1: ##1 "4.: R .001
y&e of anest(esia6 general+ n B: #9# 9.: 1"+9#9 9.4: .1
=oun/ class+ n B: .
13lean 0 ## 0.#:
"3leanIcontaminate/ #9 99.0: 1#+"0 9.:
#3ontaminate/ # 0.: 94 0.:
4,irty 1 0.#: ## 0.#:
a)oss of 10B or more of bo/y 'eig(t in t(e &re8ious mont(s not because of eercise or /ieting-
b,ata are gi8en as mean $,.
)a*e. $urgical site infections after (ysterectomy. Am J Obstet Gynecol "01#.
a/7ustment for all $$5 'as base/ on t(e
re/icti8e mo/el of 3ul8er et al11
t(at
incororate/ 'oun/ classiKcation+
A$A classiKcation+ an/ oerati8e time.;sing t(ese ris* factors+ E/'ar/s et al
"
analyHe/ nearly 000 (ysterectomies
t(at 'ere reorte/ to t(e N2$N.
(e occurrence of all ostoerati8e
$$5 suerKcial+ /ee
an/ organsace: after V2 'as 0.9B
an/ after A2 'as 1.B. ;nli*e t(e
reorts by 3ul8er et al an/ E/'ar/s et al+
our stu/y soug(t to i/entify ris* factorsfor $$5 t(at are more seciKc to (ysterectomy. y eamining 8arious ossible
7/24/2019 Pi is 0002937813006261
12/17
ris* factors+ our stu/y suggests a//itional
ris* factors+ suc( as route of
(ysterectomy+
&reo&erati8e anemia+ smo*ing status+
an/ (istory of 3VA t(at s(oul/ be
consi/ere/ in future stu/ies t(at
eamine $$5 after (ysterectomy.
Our Kn/ings are base/ on multi
institutional /ata t(at 'ere
collecte/ in a stan/ar/iHe/ fas(ion.
Olsen et al#erforme/ a multicenter
retrosecti8e
7/24/2019 Pi is 0002937813006261
13/17
A)E
)ogistic regression mo/el for association of urinary tract infection after(ysterectomy
A/7uste/
of t(e incision at t(e 8aginal cuff.
After a (ysterectomy+ an eamle of a
/ee $$5 'oul/ be consi/ere/ a
8aginal cuff abscess. =e belie8e t(at a
&el8ic abscess t(at /rains t(roug( t(e
8aginal cuff+
Variable2istory of cerebro8ascularacci/ent 'it( neurologic /eficit
o//s ratio 9>B 35 % 8alue#."9 1.41e.0 R .01
'(ic( 'oul/ be consi/ere/ as a /eesace $$5 /raining t(roug( t(esurgical incision+ is essentially similar
to a el8ic
3urrent corticosteroi/ use ".# 1.14e4.90 .0"
O&erati8e time F>t(&ercentile /uration 1. 1.>"e"."9 R .001
35+confi/ence inter8al.
)a*e. $urgical site infections after (ysterectomy. Am J Obstet Gynecol "01#.
abscess t(at reuires /rainage t(roug(
inter8entional ra/iology+ '(ic( alter
nati8ely 'oul/ be categoriHe/ as an
organsace $$5. ecause of t(e o8erla
bet'een t(ese terms+ 'e electe/ to
combine /ee an/ organsace $$5.
(e ris* factors associate/ 'it(&ost
casecontrolle/ stu/y 'it( a&&roi
mately 00 atients after A2 an/V2. (e cases an/ control sub7ects
'ere collecte/ 'it( t(e use of t(e
5nternational 3lassiKcation of,iseases+ Nint( !e8i sion+ 3linical
Mo/iKcation &roce/ure co/es for
(ysterectomy from 4 artici ating
3,3 %re8ention Eicenter %ro gram
(ositals from "00#"00>. ot( M5
F#> *gIm"
an/ intraI&ostoerati8e
bloo/ transfusion 'ere i/entiKe/ as
in/een/ent ris* factors for suerKcial
$$5 after (ysterectomy 'it(laarotomy. $imilarly+ a singleinstitution c(art re8ie' also foun/
obesity M5+ #0 *gIm": an/ bloo/
transfusion re+ intra+ an/
ostoerati8e: to be associate/ 'it( all
$$5 after ab/ominal (ysterectomy.4
2o'e8er+ ot(ers (a8e foun/ obesity
not to be a ris* factor for
osto&erati8e comlications after
gynecologic sur gery.19
=e foun/
t(at+ by consi/ering M5 F#0 *gIm"+
M5 'as i/entiKe/ as a ris*factor forsu&erKcial $$5 cellulitis:. 5n our larger
multicenter analysis+ 'e /i/ not Kn/ an
associationbet'een&re oerati8etransfusion an/ $$5. Alt(oug(
intraoerati8e transfusion 'as i/entiKe/
in our bi8ariate analysis to be associate/
'it( cellulitis an/ /eeIorgansace $$5+'e /i/ not Kn/ a statistically signiKcant
association bet'een intraoerati8e
trans fusion an/ $$5 after a/7usting
for ot(er 8ariables. (e /ifferences in
our Kn/ings an/ re8ious reortsregar/ing trans fusion bot( re an/
intraoerati8e: as a ris* factor for $$5
after (ysterectomy li*ely are relate/ to
t(e robust sam&le siHeof our
stu/y.
=e i/entiKe/ ris* factors t(at
'ere associate/ 'it( /ee an/
organs&ace
$$5 after (ysterectomy t(at inclu/e/
&reo&erati8e anemia an/ (istory of 3VA+'(ic( may be reecti8e of c(ronic &re
oerati8e systemic /isease. (ese ris*
factors are in a//ition to ris* factors of
A$A class #+ current smo*ing status+
an/ morbi/ obesity M5+ 40 *gIm":.
=e /i/ not Kn/ a statistically signiKcant
/ifference in /ee an/ organsace $$5
bet'een /ifferent (ysterectomy routes.
=e (yot(esiHe t(at our Kn/ings of
increase/ association of bot( &reo&era
ti8e anemia an/ (istory of 3VA 'it(
/ee an/ organsace $$5 may reect a/ecrease of t(e bo/ySs ability to res&on/to stressors of surgery an/ to combat
ostoerati8e infection. =e foun/ an
association bet'een reoerati8e 3VA
'it( resi/ual neurologic /eKcit an/ t(e
ris* of /ee an/ organsace $$5. 3VA
(as been note/ to be associate/ signiK
cantly 'it( any a/8erse ostoerati8e
e8ent."0
=e belie8e t(at 'e may (a8e
obser8e/ t(is relations(i because 3VA
'it( resi/ual neurologic /eKcit is a ris*
factor for functional /een/ence.
"1
3(enet al
""foun/ functional /een/ence to
be an in/een/ent ris* factor for &ost
oerati8e $$5+ seciKcally met(icillin
resistant $ta&(ylococcus aureus $$5+ in
ol/er a/ults.
=e /i/ not Kn/ /ifferences in ris*
factors for /ee an/ organsace $$5
'(en 'e eamine/ t(ese infections se
arately. =e ultimately c(ose to combine
t(ese " categories '(en eamining
$$5 after (ysterectomy. =e belie8e t(at
/ee an/ organsace $$5+ alt(oug(/eKne/ /istinctly by t(e A3$ N$?5%
an/ 3,3 criteria+ are functionally t(e
7/24/2019 Pi is 0002937813006261
14/17
same e8ent after (ysterectomy because oerati8e ;5 after (ysterectomy 'ere
a (istory of 3VA 'it( neurologic
/eKcit+ c(ronic steroi/ use+ an/
oerati8e time F>t( ercentile. =e
foun/ t(e occurrence of #0/ay
ostoerati8e ;5 'as #.0B n @
40" 'omen: after (ys terectomy.
;nfortunately+ 'e /i/ not (a8e
information on cat(eter use or
/urationbecause of limits of t(e/ataset. One (un/re/ fortyt'o
'omen 'ere i/entiKe/ as (a8ing
reoerati8e sys temic infection
t(at inclu/e/ se&sis+ se&tic s(oc*+
an/ systemic inammatory resonse
syn/rome an/ 'ere eclu/e/because
of t(e in(erent /ifference in t(ese
cases from 'omen '(o un/ergo
sc(e/ule/ electi8e surgery.
Alt(oug( t(ese con/itions may be
associate/ 'it( a greater ris* of
ostoerati8e $$5+ t(e small numbersan/ t(e 8arious /ifferent causes of
systemic infection ma/e it /ifKcult
to /ra' conclusions in t(e cur
rent stu/y.
Our stu/y (as many limitations.
(e Krst is t(at our analysis 'as
limite/ to t(e 8ariables t(at eiste/ in
t(e /atabase. or eamle+ 'e 'ere
limite/ by t(e A3$ N$?5%
/eKnition of /ee an/ organsace
$$5- t(erefore+ 'e 'ere also unable to
/istinguis( bet'een&el8ic ab scesses+8aginal cuff cellulitis+ or fasciitis.
$econ/+ seciKc 8ariables 'ere not
collecte/ in t(e general A3$N$?5% /ataset t(at 'oul/ (a8e
en(ance/ our stu/y Kn/ings. or
eamle+ t(e ty&e an/ timing ofreoerati8e&ro&(ylactic antibiotic
a/ministration+ '(ic( is a factor
lin*e/ to ostoerati8e infec
tion+"#+"4
'ere not a8ailable in t(e
/atabase. Anot(er limitation of t(is
/ataset 'as t(e lac* of informationabout t(e
7/24/2019 Pi is 0002937813006261
15/17
4
A)E
A
ll#0/ay&osto&erati8esurgical
siteinfectionsan/urinarytractinfectionsby(ysterectomyroute
n
C
1#+G
"":
4otalab/ominal
(ysterectomy+
nB
:
>0E9
9#.G
:
141
".E
:
E
1."
:
1"G
".4
:
$u&racer8ical
(ysterectomy+
nB:
EGG94
.0:
1"
.#:
G1
.1:
19"
.E:
4otal8aginal
(ysterectomy+
nB:
"9"19>.#
:
10
.E:
#"1
.0:
94#
.1:
)a&arosco&icassiste/
8aginal
(ysterectomy+n
B:
"09494.#
:
10
.:
##1
.>:
E#
.4:
4otalla&arosco&ic
(ysterectomy+
nB:
G#9>."
:
>0
.E:
40
.>:
###.G
:
)a&
arosco&ic
su&racer8ical
(ysterectomy+nB:
14
"9E.
:
"
01
.#:
100
.:
"01
.#:
4y&eo
fsurgical
siteinfection
None3
ellulitis
,ee&Io
rgan0s&ace
;rinary
tract
infection
n 1#
+01
94
.E:
"11
.E:
1>41
.1:
#0"
.:
)a*e.
$urgicalsiteinfectionsafter(ysterectomy.
Am
JObstetG
ynecol"01#.
in/ication for (ysterectomy. $urgical
roce/ures 'ere categoriHe/ by 3%
co/es alone. (e occurrence of &ost
oerati8e ;5 after rolase or anti
incontinence surgery (as been re&orte/
to be (ig(er t(an t(at foun/ in our
stu/y.">
ecause t(e 'omen 'ereselecte/ for inclusion in t(is stu/y base/
on (ysterectomy an/ not rolase or
incontinence roce/ures+ 'e 'ere not
able to /etermine t(e occurrence of
;5 after rolase or incontinence&ro
ce/ures in our current analysis.
=e /i/ not Kn/ an association 'it(
(ysterectomies t(at 'ere erforme/
for gynecologic cancer an/ $$5 base/
on 3%4 co/es. (is Kn/ing may also
be /ue to t(e lac* of s&eciKc
information in t(e /ataset regar/ingcancer stage+ gra/e+ an/ at(ologic
con/ition in t(e A3$ N$?5% /ataset.
=e 'ere limite/ to t(e i/entiKcation of
roce/ures for gyneco logic cancer
base/ on 3%4 co/es t(at in/icate/
ra/ical /issection an/ lym(a
/enectomies. A//itionally+ some
(yster ectomies for cancer t(at
reuire/ bo'el resection may (a8e
been co/e/ rimarily as colon surgery
an/ t(erefore not inclu/e/ in our
analysis. =e /i/ eamine all cancer8ariables t(at 'ere a8ailable in t(e
A3$ N$?5% /ataset inclu/ing *no'n
/isseminate/ tumor+ c(emo t(eray+
or ra/iation t(eray 'it(in
#0 /ays before roce/ure an/ *no'n
central ner8ous system tumor: bot(
in/i8i/ually an/ as a comosite grou&
an/ /i/ not Kn/ a statistically
signiKcant association 'it( $$5. (is+
again+ li*ely reects t(e limitation of
t(e /ataset because it /oes not inclu/e
cancer stage+ gra/e+ an/ /isease.
)ast+ (osital articiation in t(e
A3$ N$?5% is 8oluntary an/ conK/en
tial+ '(ic( may intro/uce selectionbias-
(o'e8er+ as of "009+ F#"0 (os&itals
'ere articiating in t(e A3$ N$?5%
&ro gram+ '(ic( inclu/e/ a 'i/e
range of community (ositals an/
tertiary care centers. (e A3$ N$?5%
&artici&antuse /ata Kles /o not allo'
for i/entiKcation of articiating
(ositals 'it(in t(e /ataset- t(erefore+
'e 'ere not able to account for t(e
effect of clustering of obser8ations'it(in centers. 2o'e8er+ re8ious
in8
est
iga
tor
s
(a
8e/e
mo
n
str
ate
/
t(a
t
t(e
clu
ste
ring
eff
ect
fro
m
t(e
7/24/2019 Pi is 0002937813006261
16/17
A$3 N$?5% for ot(er en/oints is minimal an/ /i/ not c(ange t(e o8erall
a/7uste/ outcomes.>+"
Our stu/y suggests t(at numerous factors+ '(ic( inclu/e (ysterectomy route+
oerati8e time+ /iabetes mellitus+ A$A class #+ M5+ smo*ing status+ &re
oerati8e anemia+ 3VA 'it( neurologic /eKcit+ an/ corticosteroi/ use are associ
ate/ 'it( $$5 after (ysterectomy. ,e8el oment of a &re/icti8e mo/el for $$5
after all tyes of (ysterectomy is nee/e/. ;nfortunately+ 'e cannot /e8elo a
&re /icti8e mo/el 'it( t(is current 'or* because of a lac* of a 8ali/ation
co(ort.
,ecreasing re8entable (os&ital acuire/ infections is imortant for t(esa*e of uality atient care. 5n lig(t of t(e recent national 3M$ man/ate t(at
reuires all Me/icarecertiKe/ (ositals to reort /ata an/ outcome measures
&ublicly+ t(e re8ention of $$5 'ill soon become imortant for a (ositalSs
Knancial stability as 'ell.1
(e A3$ N$?5% rogram to imro8e uality an/
atient safety (as succee/e/ by &ro 8i/ing timely+ consistent+ conK/ential+
ris*a/7uste/ fee/bac* to articiating institutions on t(e institutional occur
rence of a 'i/e range of ostoerati8e comlications.>
5nstitutions imme/i ately
can i/entify systems an/ strategies to imro8e atient outcomes in outlying areas.>
(is conK/ential ris*a/7uste/ rogram (as begun to imro8e surgical outcomes.
no'le/ge of t(e baseline occurrence of ostoerati8e $$5 after /ifferent
routes of (ysterectomy an/ associate/ ris* factors is imortant to imro8e
atient safety after (ysterec tomy by (eling to i/entify mo/iKable factors to
re8ent $$5. ecause 3M$ enforces man/atory ublic re&orting of
ostoerati8e $$5 after (ysterec tomy 'it(out ris* a/7ustment seciKc to
(ysterectomy+ careful monitoring must be use/ to i/entify uninten/e/conseuences. 0
!EE!EN3E$
1. 3enters for Me/icare an/ Me/icai/ $er8ices 3M$:+ 22$. inal rule 3M$ 149. fe/eral
register 8olume >+ number 1> Mon/ay+ august
1+ "010:DCrules an/ regulationsD Cages >0041
>0D from t(e fe/eral register online 8ia t(e go8ernment &rinting ofKce C' ' ' .g& o .g o8D
http://www.gpo.gov/http://www.gpo.gov/http://www.gpo.gov/http://www.gpo.gov/http://www.gpo.gov/http://www.gpo.gov/http://www.gpo.gov/7/24/2019 Pi is 0002937813006261
17/17
C! /oc no6 "0101909". A8ailable at6( tt& 6II
'''.g&o.go8If/sysI&*gI!"01101I(tmlI
" 0 1 1 1 9 1 9 .( tm. Accesse/ ,ec. 19+
"01".
". E/'ar/s J!+ %eterson ,+ An/rus M)+ et al.
National (ealt(care safety net'or* N2$N:
reort+ /ata summary for "00 t(roug( "00.
Am J 5nfect 3ontrol "00-#6 0 9" .
#. Olsen MA+ 2ig(am essler J+ 9 #.
. National 5nstitutes of 2ealt(. 3linical gui/e
lines on t(e i/entiKcation+ e8aluat ion+ an/ treat
ment of o8er'eig(t an/ obesity in a/ults6 t(e
e8i/ence reort. Obes !es 199-su l ":6
>1$"09 $.
. =u =3+ $c(ifftner )+ 2en/erson =G+ et al.
%reoerati8e (ematocr it le8els an/ &ost
oerati8e outcomes in ol/er atients un/ergoing
noncar/iac surgery. JAMA "00-"9 6"41 .
9. 2 eisler 3 A + A le t ti G,+ =e a 8er A )+
M e lt on )J # r /+ 3l i by =A+ Ge b (art J. 5m r o8 i ng
u ality of ca r e6 /e 8 e l o& m ent of a ris *a /7ust e /e r io er a ti 8e mor bi/i ty mo / el f o r 8a gin al (y s
te r ec t om y . A m J O b s te t Gy n ecol "0 10 -"0 "6
1# .e1 >.
10. ,o'/y $3+ ora( J+ a**umG a meH JN+
et al. actors re/icti8e of &osto&e rati8e
morbi/ity an/ cost in atients 'it( en/ome trial
cancer. Obstet Gynec o l"01"-1"06 1419" .
11. 3ul8er ,2+ 2oran 3+ Gaynes !%+ et al.
$urgical 'oun/ infection rates by 'oun/ class+
oerati8e &roce/ure+ an/ atient ris* in/e6
National Nosoc o mial 5nfectio n s $ur8eillance$ystem. Am J Me/ 1991-916 1>"$ $.
1". American 3ollege of $urgeons National
$ur gical ?uality 5mro8ement %rogram.
%artici&ant use /ata Kle. A8ailable at6
( tt& 6IIsite .ac sn s i&.o rgI &a r tici&a ntu s e /a ta
KleI. Accesse/ Aug. 1>+
"01".
1#. 2oran 3+ An/rus M+ ,u/ec* MA. 3,3I
N2$N sur8eillan c e /eKnition of (ealt( care
associat e / infection an/ criteria for s&eciKc
tyes of infections in t(e acute care setting. Am J
5nfect 3ontrol "00-#6# 0 9#".
14. o8a c $ ! . G u i/ e line s to /etermin e t( eroute
o f ( y st ere c to m y . Ob st e t Gy necol 19 9 >- >61 " #.
1>. alc on e + = alt e r s M, . 2 y ster e cto m y fo r
b e n ig n /is ease. O b st e t G yne col
" 0 0-1 11 6 > # .
1. American 3ollege of Obstetri c ians an/ Gy
necologi s ts. A3OG committee oinion no. 4446
c(oosing t(e route of (ysterect o my for benign
/isease. Obstet Gynecol "009-1146 1 1>.
1. Mu + "01".
19. 3(en 33+ 3ollins $A+ !o/gers A+
%araiso M+ =alters M,+ arber M,.
%erioera ti8e comli c ations in obese 'omen 8s
normal'ei g (t 'omen '(o un/ergo 8aginal
surgery. Am J Obstet Gynecol "00- 1 969.
e1.
"0. )iu ))+ )eung JM. %re/icting a/8erse
&osto&erat i8e outcom e s in atients age/ 0
years or ol/er. J Am Geriatr $oc "000-46
40>1 ".
"1. ernan / es G+ Goulart A3+ $antosJunior =!+ Alencar A%+ ensenor 5M+ )otufo %A.
E/ucational le8els an/ t(e function al /e&en
/ence of isc(emic stro*e sur8i8ors. 3a/ $au/e
%ublica "01"-"61 > 190.
"". 3(en